Autoantibodies in Patients With Type 1 Diabetes Mellitus

NCT00173628 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2005-12-21

No results posted yet for this study

Summary

Evaluate the autoantibodies, such as glutamic acid decarboxylase (GAD65), tyrosine phosphatase (IA-2 or ICA125), islet autoantibodies (IAA) and other associated autoimmune autoantibodies: microsomal antibodies, thyroglobulin antibodies, gastric parietal cell antibodies in patients with type 1 DM.

Conditions

Interventions

PROCEDURE

blood drawing

Sponsors & Collaborators

  • National Taiwan University Hospital

    lead OTHER

Principal Investigators

  • Yi-Ching Tung, MD · National Taiwan University Hospital

Eligibility

Min Age
1 Day
Max Age
20 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
1990-01-31
Completion
2006-12-31

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00173628 on ClinicalTrials.gov